Sevion Therapeutics
San Diego
About Sevion Therapeutics
Sevion is a biopharmaceutical company which discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The Company is advancing a pipeline of proprietary and partnered product candidates that leverages its unique antibody technology platforms. The Company’s antibody pipeline is being developed from technology that allows for the discovery of innovative biologic therapies to previously inaccessible targets, such as multispanning membrane proteins and ion channels that play an important role in multiple diseases. The Company also developed the first protein nanocage system allowing delivery of nucleic acids and other payloads to target cells.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $16.2M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2015)
- Ticker: otcqb:SVON
- Website: seviontherapeutics.com
- Phone: +1 858 909-0749
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sevion-therapeutics-1840287 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.